Global Relay Intelligence & Practice
All the latest news, insights, and publications from Global Relay.
Top stories
They will investigate the supply chain that supports US drug manufacturing.
Highlights
Article category: Event
Article category: Event
Article category: Podcasts
Article category: GRIP Extra
Article category: Videos
Implications for licensees and acquirers.
Key personnel moves across the regulated industries that we cover.
The agency’s CBER recommends building potency assurance into every stage of a therapy’s lifecycle.
Highlights
Article category: Event
Article category: Podcasts
Article category: GRIP Extra
Article category: Videos
Spotlight
Congressional inaction is a bad bet for prediction markets
Related articles
Industries Feed
Watch / Listen
Compliance
The reviewed MAR guidelines include five additional legitimate interests for delaying disclosures.
Regulation
ASIC chair Sarah Court cited risks similar to those of banned binary options in Australia.
Technology
Survey shows that simulation-based training had the greatest potential for improving analyst development.
Get full access, free for a month
This is a free article. Try Premium free for 28 days to get every article on GRIP and more – no payment details required.
What’s included:
- Every new article, plus our 5,000+ archive
- Daily regulatory insight and guidance
- Exclusive interviews and in-depth analysis
- Coverage of industry-leading events and conferences
- All podcasts and videos, featuring industry experts
- The full set of Rules Navigator tools
- An ad-free experience
Prediction markets in the spotlight